pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
607
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
muzastotug
muzastotug [INN]
Solid Tumor
$ADAG
Adagene Inc.
Phase 2
narmafotinib tartrate
narmafotinib tartrate
Metastatic Adenocarcinoma of The Pancreas
Amplia Therapeutics Ltd
Phase 2
navicixizumab
navicixizumab
Fallopian Tube Cancer
Feng Biosciences Inc
Phase 2
← prev
page 17 of 21
next →
131
Pain
89
Neurology
1
navtemadlin
navtemadlin
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Kartos Therapeutics Inc
Phase 2
naxitamab
Danyelza (naxitamab-gqgk)
Neuroblastoma
Y-mAbs Therapeutics Inc
Phase 2
nemtabrutinib
nemtabrutinib
Follicular Lymphoma
$MRK
Merck & Co., Inc.
Phase 2
nesuparib
nesuparib [INN]
Pancreatic Ductal Adenocarcinoma
Onconic Therapeutics Co Ltd
Phase 2
ninsipapogene sibarnarepvec
ninsipapogene sibarnarepvec
Head And Neck Squamous Cell Carcinoma (HNSC)
$HOOK
HOOKIPA Pharma Inc.
Phase 2
nitroxoline
nitroxoline [INN]
Muscle Invasive Bladder Cancer (MIBC)
Asieris Pharmaceuticals (USA) Inc
Phase 2
nuvisertib hydrochloride
nuvisertib hydrochloride
Secondary Myelofibrosis
Sumitomo Pharma America Inc
Phase 2
nuzefatide pevedotin
nuzefatide pevedotin [INN]
Gastric Cancer
$BCYC
BICYCLE THERAPEUTICS PLC
Phase 2
obrixtamig
obrixtamig [INN]
Small-Cell Lung Cancer
Boehringer Ingelheim International GmbH
Phase 2
ocifisertib
ocifisertib [INN]
Refractory Acute Myeloid Leukemia
Treadwell Therapeutics Inc
Phase 2
odafosfamide
odafosfamide [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphobla…
OBI Pharma Inc
Phase 2
olafertinib
olafertinib [INN]
Non-Small Cell Lung Cancer
Checkpoint Therapeutics Inc
Phase 2
olaptesed pegol
olaptesed pegol [INN]
Glioblastoma Multiforme (GBM)
TME Pharma AG
Phase 2
ompenaclid succinate
ompenaclid succinate
Metastatic Colorectal Cancer
Inspirna Inc
Phase 2
onvansertib fumarate
onvansertib fumarate
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$CRDF
Cardiff Oncology, Inc.
Phase 2
onvapegleukin alfa
onvapegleukin alfa
Cervical Cancer
Ascendis Pharma AS
Phase 2
opaganib
YELIVA (opaganib [INN])
Bile Duct Cancer (Cholangiocarcinoma)
$RDHL
RedHill Biopharma Ltd.
Phase 2
ordastobart
ordastobart
Adenocarcinoma Of The Gastroesophageal Junction
$INBX
Inhibrx Biosciences, Inc.
Phase 2
orvacabtagene autoleucel
orvacabtagene autoleucel
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
Phase 2
osemitamab
osemitamab
Gastroesophageal (GE) Junction Carcinomas
Transcenta Holding Ltd
Phase 2
ozuriftamab vedotin
ozuriftamab vedotin
Head And Neck Cancer
$BCAB
BioAtla, Inc.
Phase 2
palacaparib
palacaparib [INN]
Malignant Glioma
$AZN
ASTRAZENECA PLC
Phase 2
pamlectabart tismanitin
pamlectabart tismanitin [INN]
Refractory Multiple Myeloma
Heidelberg Pharma AG
Phase 2
pelareorep
Reolysin (pelareorep)
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$ONCY
ONCOLYTICS BIOTECH INC
Phase 2
pelcitoclax
pelcitoclax [INN]
Neuroendocrine Tumors
$AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
Phase 2
peltopepimut-s
peltopepimut-s
Cervical Cancer
ISA Pharmaceuticals BV
Phase 2
peluntamig
peluntamig
Neuroendocrine Carcinoma
Phanes Therapeutics Inc
